PLYMOUTH MEETING, Pa.-- (BUSINESS WIRE)--January 12, 2026-- ...
WAKIX 2025 Preliminary Net Revenue of ~$868 Million; 2026 WAKIX Net Revenue Guidance of $1.0 – $1.04 Billion on Track for Blockbuster Status in NarcolepsyOn Track to Extend the Pitolisant Franchise ...
LONDON (Reuters) – Canadian officials have issued a staunch defense of their decision to withdraw four athletes from a ...
The diagnosis and management of invasive fungal infections in adult patients with hematological malignancies remains a ...
Strategic collaboration expands taletrectinib global reach with a leading oncology partnerEisai will receive exclusive development, registration and commercialization rights for taletrectinib for the ...
"YOUR DOGS ARE SUPPOSED TO BE LEASHED!! … Geez Louise," the caption read.
BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting
Everyone is encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1 ...
Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced preliminary fourth quarter and full year 2025 net product revenue ...
There was an error while loading. Please reload this page.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback